Skip to content

Randomized controlled trial of balloon dilatation to reduce recurrence of moderate intrauterine adhesions

Randomized controlled trial of balloon dilatation to reduce recurrence of moderate intrauterine adhesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031216
Enrollment
Unknown
Registered
2020-03-24
Start date
2020-06-04
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Adhesion

Interventions

experimental group:A balloon was placed three weeks after the operation to dilate the uterine cavity
control group:no bloon dilate

Sponsors

Fuxing Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Understand and approve this randomized controlled trial Patients; 2. Aged 20-40 years; 3. Weight range from 50-80 kg; 4. With moderate uterine adhesion.

Exclusion criteria

Exclusion criteria: 1. a history of uterine artery embolization surgery; 2. only cervical intraoral adhesions; 3. patients with hormone replacement therapy within 3 months; 4. severe internalPatients with surgical complications; 5. pregnancy status; 6. preoperative fever or infection symptoms; 7. malignant tumors; 8. patients with a history of pelvic inflammatory disease; 9. uterine fibroids > 3cm in diameter; 10. adenomyosis; 11. patients with contraindication to anesthesia; 12. patients who do not understand or do not recognize randomized controlled trials.

Design outcomes

Primary

MeasureTime frame
Recurrence rate of intrauterine adhesions within 2 months after operation;

Secondary

MeasureTime frame
AFS classification;

Countries

China

Contacts

Public ContactLi Tianzhao

Department of Hysteroscopic Centre, Fuxing Hospital, the Eighth Clinical Medical College, Capital Medical University, Beijing

13520279748@139.com+86 18613807887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026